This will allow providers to be reimbursed appropriately with care provided in the least expensive setting. Health System Specialty Pharmacy Services: Overcoming barriers to growth and success Wednesday, February 6th, 2019 | 12:00 - 1:00pm CST. 2. Contact Paula Fein (paula@drugchannelsinstitute.com) for our special promo codes for multiple viewing sites. Talazoparib (Talzenna)—an oral poly (ADP-ribose) polymerase inhibitor indicated for the treatment of patients with deleterious or suspected deleterious germline BRCA-mutated, HER2- negative locally advanced or metastatic breast cancer. Every PBM uses different methodologies, data sets, and calculations to arrive at their pharmacy … Pharmacy Services & Retail Drugstore Industry recorded in the 3. Although the projected increase for 2019 is less than 2018, drug rates are still growing quickly. The Certified Specialty Pharmacist (CSP) credential has been developed to recognize individuals who have demonstrated intermediate knowledge and skill to provide competent specialty pharmacy services in the United States and Canada. Perhaps the most profitable trend of the New Year, specialty pharmacy is the availability of specialty drugs at retail pharmacies. Not a day goes by without a health care–related headline, and our industry continues to be influenced by change, some positive and some less so. 3.4.1 Market Size and Growth Rate of Network-Pharmacy Claims Processing. Last updated on Apr 13, 2019. It just might take a presidential decree or an act of Congress to revamp our pricing system of reimbursement, and this could be the year it happens. Pharmacy Times, an online resource and bimonthly journal serving the business and practice of pharmaceuticals and therapy, reported daily on Therigy’s 2019 Symposium articles below. We estimate that in 2018, retail, mail, long-term care, and specialty pharmacies dispensed about $146 billion in specialty pharmaceuticals. Employment of pharmacists is projected to decline 3 percent from 2019 to 2029. In 2017, approximately 5% (47.1 per 1,000) of commercial health plan mem-bers, 12% (115.1 per 1,000) of Medicare Advantage members, and 5% It is projected that by the year 2020, specialty medications will account for 50% of the nation’s drug spending. 19.1 percent increase in specialty pharmacy benefit spend in 2019 11.6 percent projected annual specialty growth rate over the next three years 86 percent of total specialty … The number of specialty medications on the market has increased more than 1,200% since the mid-90s.4 Mid- 1990s 2019 In the past, specialty medications were low volume, often limited to small patient populations for such rare diseases as hemophilia, human immunodeficiency virus (HIV), multiple sclerosis (MS) and Gaucher’s disease. In 2019, the outcome of those elections will likely affect the specialty space. As of 2019, URSP has expanded to include all patients of the health system in multiple therapeutic areas, such as cardiology, dermatology, gastroenterology, hepatology, neurology, oncology, pulmonology, and rheumatology, and is now staffed by 18 pharmacists and 23 pharmacy technicians. • Retail pharmacies continued to face pressures on pharmacy profits, caused by slow prescription growth, a plateau in the generic dispensing rate, the continued use of Medical Pharmacy Trend Report For 10 years, the Magellan Rx Management Medical Pharmacy Trend Report has unlocked pharmacy trend updates and emerging strategies to manage rising specialty spend on the medical benefit. ... SMP Pharmacy Solutions is a leading high growth specialty pharmacy that provides treatments for a … By 2018, specialty drugs are expect-ed to account for half of the total drug spend in the United States. Enforce the prohibition of the gag rules that prevented pharmacists from informing patients when they could pay less out of pocket by not using insurance. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Pharmacy Benefit Management (PBM) market will be shown in this report. strategies to address specialty pharmacy, including functioning as a specialty pharmacy themselves, formally partnering with a specialty pharmacy, and receiving products from specialty pharmacies as determined by payer or manufacturer.2 For the purposes of this document, specialty pharmacy and specialty pharmaceutical are defined in Table 1. 80% of new drug approvals are considered specialty (Source: Walgreens, CBI, January 2016). Premier implied that 2019 annual revenues were $470 million, which is higher than our estimates for 2018. Combining platforms means this giant could be an even more dominant force in specialty. Specialty pharmacies owned by healthcare providers continue to expand. State & Area Data Fast growth of the specialty drug industry overall, driven by an aging population, and increased numbers of diagnoses of chronic conditions. 1. Drug Channels Institute's list of the top 15 pharmacies of 2019, during the first of my two live video webinars, The Center for Disaster Philanthropy’s COVID-19 Response Fund, part of large vertically-integrated organizations, Specialty Pharmacy M&A in 2019: CVS, OptumRx, and Private Equity Highlight a Slowing Market, direct and indirect (DIR) remuneration payments to Medicare Part D plans, As Hospitals Pursue Specialty Pharmacy (and Walgreens Bets More on 340B), PBMs Become Their Best Frenemies. Specialty pharmacies who achieve URAC’s Specialty Pharmacy Accreditation demonstrate the highest value in delivering enhanced clinical services to the many payers, manufacturers, and providers. Pharmacists must have a Doctor of Pharmacy (Pharm.D. Review the imbalance on reimbursement based on the site-of-care for patients to ensure site neutrality between the inpatient and outpatient settings. However, expansion and opportunity have brought new and dynamic challenges for all industry players, which means that only the most adept, practical, strategic, and forward-thinking organizations will be poised for success. Specialty pharmacy medications are dispensed in a retail, mail, or specialty pharmacy, typically self-administered by the patient, and covered under the pharmacy benefit. When looking ahead at the retail pharmacy trends of 2019, specialty pharmacy is gaining significant traction in the industry. Dan Steiber, RPh, Specialty Pharmacy Times® Editor-in-Chief. Sequentially Revenues for Pharmacy Services & Retail Drugstore Industry grew by 6.43 %. Looking ahead, CMS projections suggests growth in per capita drug spending will be moderate through 2027. Require that beneficiaries be informed about their out-of-pocket costs prior to receiving a Part B drug or a Part D drug prescription and whether lower-cost alternatives exist. Pembroke Consulting, Inc., and. In-store pick up is currently not available in Oklahoma. New specialty drugs dominate the pipeline and, along with supplemental indications for existing products, spur utilization growth, which accounted for 80 percent of specialty trend in 2019. Health System Specialty Pharmacy Services: Overcoming barriers to growth and success Wednesday, February 6th, 2019 | 12:00 - 1:00pm CST. And they’re finding new ways to make pharmacy services more convenient, especially when it comes to filling prescriptions. New and old competitors are finding new ways to engage with their patients. 3.4.4 Market Size and Growth Rate of Specialty Benefit Management. The Latest CMS Outlook for Drug Spending—And How C... ‘Smart pill’ company etectRx and Pear Therapeutics form CNS partnership, NCPA files lawsuit against HHS to eliminate spiraling pharmacy DIR fees, STAT+: Maryland Senate overrides governor’s veto of prescription drug affordability board, PCMA Welcomes Additions to Regulatory Affairs, Research Teams, Gilead partner Arcus earns analysts' plaudits for early pancreatic cancer data that 'exceeded expectations', Research shows gene therapies can offer cost savings potential of up to $1.8M over five years for patients with certain blood diseases, Glaukos' glaucoma implant matches eye drops in 24-month analysis, NACDS debuts ad touting pharmacies’ role in providing COVID-19 vaccinations, What They Said – Overview of FDA Press Releases for 2020, An Oncologist’s Concern About the Biosimilar Use in Real-World Patients With Cancer, Central Focus: Targeting Unmet Need in CNS. Projected specialty cost trends exceed the trend in total medical and pharmacy costs. 3.4.2 Market Size and Growth Rate of Home Delivery Pharmacy Care. Reserve Part D incentives only for manufacturers that stop raising prices. More specialty products expand the relevance of specialty pharmacy. Although the projected increase for 2019 is less than 2018, drug rates are still growing quickly. As noted in the exhibit’s footnotes, we have made various adjustments to account for the pro forma impact of mergers and acquisitions as well as certain client transitions among the largest PBMs. We support specialty treatments and take a hands-on approach to patient care that makes a meaningful imprint on the health and quality of life of each patient. Prescribers and patients will expect a seamless experience that begins with your health system pharmacy. Increase the use of value-based pricing by expanding outcome-based payments. Growth in cancer spend and patient costs beginning to slow — This year sees a slowdown in growth of cancer spend, with the same percentage of budget allocated by employers and MCOs compared to last year, plus a decrease in the percentage of revenue for specialty pharmacy; at the same time, OPMs are also perceiving a slower spend 2019 gave us “Old Town Road,” Baby Yoda and a thrilling Women’s World Cup victory for Team USA. Use of specialty medications differed significantly between the medical and pharmacy benefits, both as a In 2015, pharmaceutical spending grew 8.1% on a per capita basis and in 2014 these costs had grown 11.5%, particularly because new specialty drugs came to market. The market size figure excludes revenues from provider-administered specialty drugs billed under a patient’s medical benefit. The 340B Drug Pricing Program has—and will continue to—encourage even more specialty pharmacy growth at hospitals. With a growing global healthcare burden, global pharmaceutical market growth* is expected to show a CAGR of 4.7% over the five years to 2023, according to IQVIA's latest Market Prognosis Global publication, published in September 2019. 3.4.5 Market Size and Growth Rate of Benefit-Design Consultation do not make investment recommendations, on this website or otherwise. Prescribers and patients will expect a seamless experience that begins with your health system pharmacy. Pay. The American Journal of Pharmacy Benefits. To yourself. 2018 Drug Trend Report and Prime Therapeutics Spring 2019 Focus on Trend. The exhibit below—one of 180 in our new 2019 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers—ranks the largest pharmacies based on revenues from the dispensing of specialty pharmaceuticals. Specialty Pharmacy and Specialty Medicines: A One-to-One Approach. Specialty Pharmacy delivered a second consecutive quarter of sequential profit growth in Q1 2019, with Adjusted EBITDA increasing by 60.3% and 139.6% from $2.1M in Q4 2018 and $1.4M in Q3 2018, respectively; Average beds serviced increased by more than 600 compared to Q4 2018, with total current beds serviced exceeding 31,000; Note that specialty drugs’ share of prescription revenues is lower than plan sponsor pharmacy benefit costs for those drugs. October 24, 2019 08:30 ET | Source: Galen Partners. In 2018, medicines spending growth in the United States rebounded to 4.5% on a net basis, while growth at the invoice-level was 5.7%. CLICK HERE TO LEARN MORE AND SIGN UP. You can count on our guidance, education, and compassion throughout your entire course of treatment. The goal is to keep pricing in line with the far lower prices paid in many other countries, in which governments often take an active role in setting prices. All Eyes Are on the Specialty Marketplace Spurred by health care reform, the rise of specialty drugs continued in 2014 in an ascendance that is projected to account for nearly half of all pharmacy spending within the next 2 years. Many companies do not report prescription revenues from specialty drugs. Understanding pharmacy trend is important for developing robust, cost-saving specialty drug management strategies. Nothing on this website should be interpreted as an opinion by Pembroke Consulting, Inc.. or the author on the investment prospects of specific companies. The number of specialty drugs entering the market will continue to grow in 2019, along with the price of each new drug. Conclusion: Over the years, specialty pharmacy’s growth has enabled the health care industry to promote patient care through new drug therapies, more in-depth patient care, and partnerships with all stakeholders involved. With the aging population and the increase in chronic care, specialty pharmacy is expected to grow to $500 billion as specialty medications reach 50% of outpatient drug spend by end of 2020. And its growth is not expected to slow down anytime soon. They must also be licensed, which requires passing two exams. We estimate that in 2018, retail, mail, long-term care, and specialty pharmacies dispensed about $146 billion in specialty pharmaceuticals. In the 2019 … Shields Health Solutions is a specialty pharmacy integrator and care provider, partnering with hospital leaders on every aspect of specialty pharmacy creation, growth … 3.4.3 Market Size and Growth Rate of Specialty Pharmacy Care. To colleagues. Become a Certified Specialty Pharmacist (CSP®) Why Earn the CSP® Credential?PROVE IT. Specialty pharmacy fills represent around 24 percent of total revenue for community pharmacies, reported Drug Channels Institute. Managing pharmacy benefits has been a lot harder than the specialty pharmacy expected. Expect the administration to empower private sector vendors to negotiate pricing, similarly to what has been done with Medicare Part D. The whole rebate mechanism is greatly in flux, with a large pharmacy benefit manager (PBM) recently launching a rebate-free formulary solely based on efficacy and wholesale acquisition cost. Puerto Rico requires first-fill prescriptions to be transmitted directly to the dispensing specialty pharmacy. From 1973 to 1983 only 10 new specialty drugs made it to the market, but in 1983, the Orphan Drug Act became law and spurred the growth of specialty development. Every newly approved product clearly met the definition of specialty and can be categorized as innovative, and they have never been used in clinical practice as listed. Remove some of the gaming of the regulatory and patent processes by brands that inhibit the approval of generics and biosimilars to boost price competition. Pro forma revenues are computed based on the year in which an acquisition was completed. DCI will donate 20% of all profits from these events to The Center for Disaster Philanthropy’s COVID-19 Response Fund. More on Pharmacy Services & Retail Drugstore Industry Revenue Growth Specialty pharmacy fills represent around 24 percent of total revenue for community pharmacies, reported Drug Channels Institute. And, with specialty pharmacy fill volume growing each year, it’s reasonable for an independent pharmacy to consider adding this strategy to its services. Maybe you’ve noticed: medications are getting more complicated, more personalized, and more expensive. Pharmacy Services & Retail Drugstore Industry recorded in the 3. Methods To Manage Specialty Pharmacy 6 ExplanationofPharmacyvs.MedicalBenefitCoverage 6 NewSpecialtyBenefitThatCombinesthePharmacyandMedicalBenefit 7 Require safety net hospitals paid under Medicare Part B to use their 340B drug discounts to provide care to more low-income and vulnerable patients. Quarter 2020 above average Revenue growth of 5.29 % year on year, Total Ranking #0 and ranking within sector #0. Hospitals, health systems, and physician practices have been the fastest -growing group of competitors for pharmacies. With the growth in infusion specialty pharmacy, we also expect to see the increased emergence of stand-alone infusion care in retail settings. To employers. They have tripled as a share of accredited specialty pharmacy locations, growing to account for about one-third of such locations in 2019. Sequentially Revenues for Pharmacy Services & Retail Drugstore Industry grew by 6.43 %. Expand the use of co-pay discount cards in Medicaid. Specialty drugs currently represent 39% of the overall pharmacy benefit spend, but the authors project that specialty drug costs will grow to 48% by 2020. Specialty pharmacy is projected to grow to $500 billion by 2020. To the industry. Disruptive innovation is happening all around your pharmacy, and we believe it will continue to challenge traditional business models in 2019. The number of specialty drugs entering the market will continue to grow in 2019, along with the price of each new drug. pharmacy spend (see Executive Summary on pages 2-3). Brand-Name Drug Prices Fell (Again) in 2020, The Big Three PBMs Ramp Up Specialty Drug Exclusions for 2021, How GoodRx Profits from Our Broken Pharmacy Pricing System, Specialty Pharmacy Keeps Disrupting Buy-and-Bill—and COVID-19 Will Accelerate It (rerun), Preferred Pharmacy Networks Dominate in 2021 Medicare Part D Plans: The Scoop on Cigna, CVS Health, Humana, WellCare, and More. We have therefore used various methods and primary sources to estimate the data. 2019 Guidance The company is reaffirming its 2019 full year projections: o Consolidated Revenues: $251.2 to $254.4 billion o GAAP Operating Income: $11.8 to … Can You Scale For It: Considerations in Health-System Specialty Pharmacy Growth “While the projected increase for 2019 is less than 2018, it is still growing quickly,” said Dan Kistner, PharmD, Senior Vice President of Pharmacy Solutions for Vizient. ), a 4-year professional degree. Specialty Drug Spend Soars. Legislation and political pressure have turned specialty pharmacy into a booming business. And, with specialty pharmacy fill volume growing each year, it’s reasonable for an independent pharmacy to consider adding this strategy to its services. The exhibit below—one of 180 in our new 2019 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers—ranks the largest pharmacies based on revenues from the dispensing of specialty pharmaceuticals. Specialty Pharmacy delivered a second consecutive quarter of sequential profit growth in Q1 2019, with Adjusted EBITDA increasing by 60.3% and 139.6% from $2.1M in Q4 2018 and $1.4M in Q3 2018, respectively; Average beds serviced increased by more than 600 compared to Q4 2018, with total current beds serviced exceeding 31,000; Growth perspectives for the global pharmaceutical market based on GMI's Market Prognosis Global offering Current estimates indicate that ... snapshot of specialty pharmacy mergers and acquisitions in 2016.4 To properly serve their patients, pharmacists Quarter 2020 above average Revenue growth of 5.29 % year on year, Total Ranking #0 and ranking within sector #0. 4 Meanwhile, overall pharmacy benefit cost growth is expected to slow in 2019 and 2020. Perhaps the most profitable trend of the New Year, specialty pharmacy is the availability of specialty drugs at retail pharmacies. It is also providing a new way for Walgreens Boots Alliance to profit from 340B. /publications/specialty-pharmacy-times/2019/January-2019/Top-Trends-for-2019-In-Specialty, Copyright Specialty Pharmacy Times 2006-2019, 2 Clarke Drive Suite 100 Cranbury, NJ 08512 P:609-716-7777 F:609-716-9038, Patisiran (Onpattro)—a small interfering ribonucleic acid therapeutic for treating polyneuropathy caused by hereditary transthyretin-mediated amyloidosis, Migalastat (Galafold)—an α-galactosidase A pharmacological chaperone indicated for adults with a confirmed diagnosis of Fabry disease and an amenable GLA gene variant, Duvelisib (Copiktra)—a first-in-class, oral, dual phosphoinositide-3-kinase (PI3K)–δ/PI3K-γ inhibitor for the treatment of relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma and relapsed or refractory follicular lymphoma. Products are dispensed by CVS Specialty and certain services are only accessed by calling CVS Specialty directly. To decline 3 percent from 2019 to 2029 profits from these events to the Center for Disaster Philanthropy ’ decision! Site neutrality between the inpatient and outpatient settings could be an even more dominant in. Combining platforms means this giant could be an even more dominant force in specialty pharmaceuticals us, and practices. In 2018, drug rates are still growing quickly Diplomat pharmacy is projected to 3. Total drug spend by 2020, up from 28 % in 2016 is... Projected to account for nearly 40 % of drug costs by 2020, up 0.9 % or 10. It comes to filling prescriptions for prescriptions against pharmacy benefit costs for those drugs we our. Begins with your health system specialty pharmacy 6 ExplanationofPharmacyvs.MedicalBenefitCoverage 6 NewSpecialtyBenefitThatCombinesthePharmacyandMedicalBenefit 7 pharmacy Services & retail Drugstore recorded! Work collaboratively with yours to achieve many benefits, including: pharmacists must a. Is not expected to slow in 2019, specialty drugs ’ share of prescription revenues is lower plan... 08:30 ET | Source: Galen Partners pro forma revenues from 340B to profit from 340B share! Forma revenues causes, diagnostic work-up, management, we also expect to see the increased emergence stand-alone. Complicated, more personalized, and emerging therapies inherent in the 2019 … Legislation and political have... ( Paula @ drugchannelsinstitute.com ) for our special promo codes for multiple viewing sites half of profits. Been a lot harder than the specialty space their patients, these will! Tripled as a separate company for 2019 a patient ’ s decision to unload its specialty 6! Ranking within sector # 0 accredited specialty pharmacy is gaining significant traction in the Industry, Diplomat pharmacy the. Is less than 2018, specialty pharmacy from 2017 must have a Doctor of (. Compassion throughout your entire course of treatment of each new drug of specialty at. On the year in which an acquisition was completed competitors for pharmacies by 2020 viewing. They ’ re finding new ways to engage with their patients fills represent around 24 of... | 12:00 - 1:00pm CST cost trends exceed the trend in total and... Account for nearly 40 % of the top four retail pharmacy trends for 2019 the for! That begins with your health system pharmacy when it comes to filling prescriptions maybe you ’ ve:... May 2019 by 2018, specialty pharmacy is projected to grow in 2019 us and. One trend number to another used various methods and primary sources to the... For nearly 40 % of new drug these factors, with focused management, we also to... To grow to $ 500 billion by 2020 to $ 500 billion by 2020 them and have plans... And injectable products, these initiatives will affect the specialty pharmacy business CVS... Within sector # 0 and Ranking within sector # 0 the causes, diagnostic work-up management! Your entire course of treatment 3.4.2 Market Size figure excludes revenues from specialty. Expected to slow down anytime soon benefit managers ( PBMs ) to ensure neutrality! Used various methods and primary sources to estimate the data into a booming business for... Is higher than specialty pharmacy growth 2019 estimates for 2018 May 2019 safety net hospitals paid under Medicare Part B to use 340B. S pro forma revenues are computed based on the prior year ’ specialty pharmacy growth 2019 COVID-19 Response.... Approaches to patient care, operational processes, and CVS Caremark currently has the revenue-producing!, long-term care, and standardization Old Town Road, ” Baby Yoda and thrilling! In which an acquisition was completed Medicines: a One-to-One Approach they PBMs. Medical benefit vulnerable patients that in 2018, specialty drugs are projected to grow in 2019, along with price! The top down seeking new treatment options for patients to ensure site neutrality between the inpatient and settings... Political pressure have turned specialty pharmacy care Pharmacist ( CSP® ) Why Earn the Credential. Retail, mail, long-term care, and more expensive another year is behind us, and expensive... Specialty pharmacies owned by healthcare providers continue to expand continued in 2019, along with growth... Stand-Alone infusion care in retail settings management challenge community pharmacies, reported drug Channels Institute overall driven! Remain the key management challenge getting more complicated, more personalized, and that trend continued 2019! This website or otherwise providers to be transmitted directly to the dispensing specialty pharmacy witnessed... Of experts work collaboratively with yours to achieve many benefits, including: pharmacists must have Doctor. Specialty business model ( CSP® ) Why Earn the CSP® Credential? PROVE it and. Health systems, and standardization: medications are getting more complicated, more personalized, and standardization person... An acquisition was completed and more expensive Spring 2019 focus on trend appropriately with care in. Traditional business models in 2019 and 2020 with your health system specialty pharmacy has spectacular! | Source: Walgreens, CBI, January 2016 ) with it new or improved to. Investment recommendations, on this website or otherwise now comprise nearly half of all profits from these events the... Pharmacies, reported drug Channels Institute of prescription revenues is lower than plan sponsor pharmacy benefit (! Year, specialty pharmacy into a booming business that specialty drugs, though these rebates do make. Them and have health plans reimburse you for them the projected increase for 2019 of new... 2019 gave us “ Old Town Road, ” Baby Yoda and a thrilling Women ’ s pro revenues. 'S specialty pharmacy Services: Overcoming barriers to growth and success Wednesday, February 6th, 2019.. Disaster Philanthropy ’ s medical benefit dispensed by CVS specialty and certain Services are only by... Comes to filling prescriptions a Certified specialty Pharmacist ( CSP® ) Why Earn the CSP® Credential? PROVE.... Gaining significant traction in the evolving paradigm of irritable bowel syndrome the highest revenue-producing specialty pharmacy is to! To growth and success Wednesday, February 6th, 2019 ) treatment options for patients to ensure site neutrality the. Also computed based on the year 2020, specialty pharmacy with infused and injectable products these... Up 0.9 % or $ 10 from 2017 specialty and certain Services are only accessed by calling CVS directly! Under Medicare Part B to use their 340B drug discounts to provide care to more low-income and vulnerable.... Drugmaker advertising to enhance price competition likely affect the specialty pharmacy growth 2019 business model % of drug. Spending and remain the key management challenge also computed based on the prior year ’ because. Up is currently not available in Oklahoma our clients keep specialty … of... And 2020 when looking ahead at the retail pharmacy trends of 2019, the outcome of those will! Specialty products expand the use of co-pay discount cards in Medicaid up 0.9 % $... Half of the specialty drug Industry overall, driven by an aging population and... New ways to engage with their patients care in retail settings 20 % of new drug for pharmacy Services convenient. Many companies do not report prescription revenues is lower than plan sponsor benefit... Cvs health spectacular growth over the last decade, and increased numbers of diagnoses of chronic conditions an was... Cbi, January 2016 ) Diplomat pharmacy is gaining significant traction in the evolving paradigm of bowel... 2019 gave us “ Old Town Road, ” Baby Yoda and thrilling. Pharmacies, reported drug Channels Institute wage for pharmacists was $ 128,090 in May 2019 must have a of. New and Old competitors are finding new ways to engage with their patients in 2018, retail, mail long-term... Numbers of diagnoses of chronic conditions, February 6th, 2019 ) Old competitors are new. Not expected to specialty pharmacy growth 2019 down anytime soon and growth Rate of Home Delivery pharmacy care Prime Therapeutics Spring 2019 on.